Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown ...
A personalized mRNA vaccine may change melanoma treatment, with 70% of patients cancer-free after 5 years. Discover how this ...
Researchers delivered GM-CSF mRNA to the endometrium using targeted nanoparticles. Implantation was restored in injured mouse ...
Andrew L. Pecora, MD, discusses the significance of the long-term findings from the KEYNOTE-942 trial of intismeran autogene ...
A number of companies presented new data on their cancer vaccine candidates at ASCO 2026.
Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 10:00 AM EDTCompany ParticipantsStéphane Bancel - CEO ...
Morning Overview on MSN
A Boston-area trial just showed a single once-a-year shot of an mRNA vaccine pushed pancreatic-cancer patients into remission — built on each tumor’s own gen…
Eight people who had surgery for pancreatic cancer and then received a vaccine built from their own tumor DNA have now gone ...
Researchers have identified how cells recognize and suppress transposons, mobile DNA elements that can destabilize genomes.
Biotech is starting to sound less like medicine and more like software, and SpaceX and Tesla CEO Elon Musk thinks that shift ...
Adding intismeran autogene to pembrolizumab reduces the risk of relapse and distant metastasis in patients with resected high ...
Korro is a biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA ®) platform to develop a new class of genetic medicines for rare and highly prevalent diseases.
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results